Announcements Trials
Browse Landscape

Phase

Phase 2 78Phase 3 27Phase NA 7Phase 4 6Phase 2/3 5Phase 1/2 5Phase 1 5Phase EARLY_PHASE1 3

Status

Completed 89Terminated 25Recruiting 18Active not recruiting 15Withdrawn 7Unknown 5Not yet recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1NETWORK 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 3Other solid neoplasm 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Solid Tumor 1Non-squamous Cell Non-Small Cell Lung Cancer 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 49fludarabine 37Injections 32Gemcitabine 24Paclitaxel 23Cisplatin 21pembrolizumab 19Radiotherapy 19toripalimab 18Carboplatin 17Capecitabine 17Fluorouracil 15Oxaliplatin 13Nivolumab 12Docetaxel 12camrelizumab 11apatinib 11Temozolomide 11Cetuximab 11Bevacizumab 10Irinotecan 9Immunotherapy, Adoptive 9Drug Therapy 9Etoposide 8sintilimab 7Radiosurgery 7Peripheral Blood Stem Cell Transplantation 7Leucovorin 7Ipilimumab 7Indium 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Unknown × Pemetrexed × Clear all
NCT06116240 2023-11-03

A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Unknown
135 enrolled
Other solid neoplasm

Solid Tumor

NCT05273814 2022-07-13

Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 1 Unknown
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03626922 2022-06-10

Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients

NSABP Foundation Inc

Phase 1 Unknown
33 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03987867 2020-07-07

Study of Autologous CIK Cell Immunotherapy Combination With PD-1 Inhibitor and Chemotherapy in the Advanced NSCLC

Tianjin Medical University Cancer Institute and Hospital

Phase 1 Unknown
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03790228 2020-04-15

Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC

Henan Cancer Hospital

Phase 1 Unknown
43 enrolled
Thoracic

Non-squamous Cell Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡